These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32194013)

  • 1. Recalibrating the anti-corruption, transparency, and accountability formula to advance public health.
    Wierzynska A; Steingrüber S; Oroxom R; Bauhoff S
    Glob Health Action; 2020; 13(sup1):1701327. PubMed ID: 32194013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-corruption, Transparency and Accountability: Case Study of Healthcare in the Arab Countries.
    Hunter M; Uwaydah Mardini R; El-Seblani A; Elsayed S
    Glob Health Action; 2020; 13(sup1):1704529. PubMed ID: 32194015
    [No Abstract]   [Full Text] [Related]  

  • 4. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 5. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Kohler JC; Bowra A
    Global Health; 2020 Oct; 16(1):101. PubMed ID: 33081805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corruption and health care system].
    Marasović Šušnjara I
    Acta Med Croatica; 2014 Jun; 68(3):243-6. PubMed ID: 26016214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting anti-corruption, transparency and accountability in the recruitment and promotion of health workers to safeguard health outcomes.
    Kirya MT
    Glob Health Action; 2020; 13(sup1):1701326. PubMed ID: 32194012
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
    Gorodensky A; Bowra A; Saeed G; Kohler J
    BMJ Open; 2022 Dec; 12(12):e064137. PubMed ID: 36549737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploration of anti-corruption and health in international organizations.
    Bowra A; Saeed G; Gorodensky A; Kohler JC
    PLoS One; 2022; 17(8):e0269203. PubMed ID: 35917329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corruption in global health: the open secret.
    García PJ
    Lancet; 2019 Dec; 394(10214):2119-2124. PubMed ID: 31785827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Global Fund: why anti-corruption, transparency and accountability matter.
    Chang Z; Rusu V; Kohler JC
    Global Health; 2021 Sep; 17(1):108. PubMed ID: 34537059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review.
    Griffore KA; Bowra A; Guilcher SJT; Kohler J
    Global Health; 2023 Nov; 19(1):91. PubMed ID: 38001483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. For a honest Maghreb care system. Systematic Review of the International Literature on Corruption in the Health care System.
    Kacem M; Melki S; Nouira S; Khelil M; Sriha Belguith A; Ben Abdelaziz A
    Tunis Med; 2019 Mar; 97(3):397-406. PubMed ID: 31729714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing corruption in humanitarian assistance: perceptions, gaps and challenges.
    Maxwell D; Bailey S; Harvey P; Walker P; Sharbatke-Church C; Savage K
    Disasters; 2012 Jan; 36(1):140-60. PubMed ID: 21623891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opening the Policy Window to Mobilize Action Against Corruption in the Health Sector Comment on "We Need to Talk About Corruption in Health Systems".
    Mackey TK
    Int J Health Policy Manag; 2019 Nov; 8(11):668-671. PubMed ID: 31779293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sustainable development goals as a framework to combat health-sector corruption.
    Mackey TK; Vian T; Kohler J
    Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I Know It When I See It: The Challenges of Addressing Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems".
    Kohler JC
    Int J Health Policy Manag; 2019 Sep; 8(9):563-566. PubMed ID: 31657180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good veterinary governance: definition, measurement and challenges.
    Msellati L; Commault J; Dehove A
    Rev Sci Tech; 2012 Aug; 31(2):413-30. PubMed ID: 23413724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.